News
Media
All VideosMedical World NewsPodcastsWeekly RecapCure ConnectionsInsightsSpecial ReportNeurologyLive Peer ExchangeMedcastPeers & PerspectivesRoundtable Discussions
Conferences
Conference CoverageConference Listing
CME/CE
More
Partners
Publications
NeurologyLiveBridging the GapsInternational Journal of MS Care
Resources
Expert AuthorsFDA NewsFeaturesFellows' CornerFuture Leaders in NeurologyGiants of Multiple SclerosisInteractive ToolsJob BoardLive EventsNeurology ResourcesSponsoredVirtual Events

Subscribe

  • News
  • Media
  • Conferences
  • CME/CE
  • Partners
  • Publications
  • Resources
  • Subscribe
  • Dementia and Alzheimer Disease
  • Epilepsy
  • Genetic Disorders
  • Headache and Migraine
    • Migraine
  • MS and Demyelinating Disorders
    • NMOSD
    • Multiple Sclerosis
    • MS Advanced Practice Providers
  • Movement Disorders
    • Parkinson Disease
  • Neuromuscular
    • Chronic Inflammatory Demyelinating Polyneuropathy
    • Muscular Dystrophy
    • Ataxia
  • Rare Diseases
  • Sleep Disorders
    • Narcolepsy
    • Insomnia
  • Stroke
Spotlight -
Expert Authors|
FDA News|
AANEM 2025|
ECTRIMS 2025|
MDS 2025|
NSGC 2025
Advertisement

Scott Newsome, DO, MSCS, FAAN

Advertisement

Articles by Scott Newsome, DO, MSCS, FAAN

Use of MRI in Diagnosing Multiple Sclerosis

ByFred Lublin, MD,Patricia K. Coyle, MD,Scott Newsome, DO, MSCS, FAAN,Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC
December 23rd 2020

2017 Changes to the McDonald Criteria: Diagnosing Multiple Sclerosis

ByFred Lublin, MD,Patricia K. Coyle, MD,Scott Newsome, DO, MSCS, FAAN,Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC
December 16th 2020
  • Prev
  • 1
  • 2
  • 3
  • Prev
Advertisement


Advertisement
Advertisement

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

1

FDA Clears Phase 2a Clinical Trial to Test JOTROL in Patients With Parkinson Disease

2

OnabotulinumtoxinA Fails to Meet Primary End Point in Phase 3 PRECLUDE Trial for Episodic Migraine

3

Next Phase of Genetic Counseling in Clinical Trials: Derek Ansel, MS, CGC

4

FDA Action Update, October 2025: Clearance, Acceptance, and Extension

5

Doxecitine/Doxribitine Approval Redefines Care in Thymidine Kinase 2 Deficiency: Fabian Somers, PhD

  • About Us
  • Advisory Board
  • Editorial
  • Contact Us
  • Advertise
  • Contact MJH LS
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
HCP Live
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us